Trial Profile
Efficacy and safety of gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes (T2D).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2017
Price :
$35
*
At a glance
- Drugs Gemigliptin (Primary) ; Gemigliptin/metformin (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INICOM
- 24 Nov 2017 New trial record